How to Play Gold Po...
Health Care: Drugs
ARCA biopharma Inc. (ABIO: NASDAQ)
$2.51 0.17 | 7.26%
05/21/13 - 03:49 PM ET
56.07K / 125.30K
Vol / Avg. Vol:2.39 / 2.34
Open / Prev. Close:2.35 - 2.60
Today's Range:1.38 - 5.93
52 Wk Range:2.63%
Performance YTD:TheStreet Rating:
Portfolios with ABIO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Userbuddy62370 Portfolio 1
- UserKumaran
- UserSUPRATRADE NEW-BUY LIST-240...
Latest ABIO Headlines from TheStreet
- 5 Stocks Under $10 Triggering Breakouts 03.14.13 | 01:03 pm
- 5 Biotech Stocks Under $5 Blasting Off 08.16.12 | 03:08 pm
- 8 Stocks Under $10 Skyrocketing Higher 07.19.12 | 01:07 pm
- InfoLogix, Netlist: Midday Volume Plays 05.17.10 | 01:05 pm
- Arca BioPharma Patent Deja Vu: BioBuzz 03.29.10 | 06:03 am
- Sirius XM, ARCA biopharma: Early Volume Plays 03.26.10 | 09:03 am
- Brazilian Telecom, Agria: Midday Volume Plays 11.24.09 | 01:11 pm
- ARCA, FortuNet: Midday Volume Plays 11.23.09 | 01:11 pm
- Funds Sell $4M Worth of Pain Therapeutics 06.11.09 | 09:06 am
- Ford, Deere, Cisco Systems Are Big Movers 06.01.09 | 05:06 pm
Press Releases for ABIO
- CEO Of ARCA Biopharma To Speak On Changing Paradigms In Drug Development At ACC.13 Conference On March 10, 2013 - Business Wire 03.08.13 | 08:03 am
- ARCA Biopharma, Inc. Announces Reverse Stock Split - Business Wire 03.05.13 | 09:03 am
- Unmet Medical Need In Treatment Of Heart Failure Patients With Atrial Fibrillation Highlighted In Articles In Inaugural Issue Of JACC: Heart Failure - Business Wire 02.06.13 | 04:02 pm
- New Adaptive Phase 3 Trial Planned For GencaroTM in Atrial Fibrillation - Business Wire 01.29.13 | 05:01 pm
- GencaroTM Effect On Reducing Ventricular Arrhythmias Paper Published In Circulation: Arrhythmia And Electrophysiology - Business Wire 01.03.13 | 09:01 am
- GencaroTM Cardiovascular Effect On Patients With Atrial Fibrillation Paper Published In European Journal Of Heart Failure - Business Wire 12.12.12 | 09:12 am
- GencaroTM Pharmacogenetic Effect Paper Published In Peer Reviewed Journal PLOS ONE - Business Wire 10.10.12 | 05:10 pm
- ARCA Announces Death Of Board Chair Richard B. Brewer, Trailblazing Biotechnology Industry Veteran And Patient Advocate - Business Wire 08.16.12 | 04:08 pm
- GencaroTM's Norepinephrine Lowering Likely Contributes To Its Effect In Atrial Fibrillation Prevention - Business Wire 03.26.12 | 12:03 pm
- GencaroTM Atrial Fibrillation Data Selected For Presentation At American College Of Cardiology 61st Annual Scientific Session & Expo - Business Wire 03.20.12 | 08:03 am
Partner Headlines for ABIO
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Top Percentage Gainers and Losers as of 2pm 05/13/11 (ABIO, GFRE, DDS, APL, DF, VRML, DAR, SWSH, ONTY, GS, RMBS, LPHI, GGS, CA, NVDA, IMRS, MNTX, MPG, GTY) - Benzinga 05.13.11 | 02:05 pm
- Morning Market Movers (ABIO, LBIX, CGNX, AEIS) - Benzinga 05.03.11 | 09:05 am
- UPDATE 1-Arca reaches agreement with FDA on heart-drug study - Reuters 05.17.10 | 09:05 am
- UPDATE 1-ARCA gets U.S. patent related to heart drug; shrs soar - Reuters 03.26.10 | 10:03 am
